Transcription of 1151 PHARMACEUTICAL DOSAGE FORMS
{{id}} {{{paragraph}}}
Example: biology
1151 PHARMACEUTICAL DOSAGE FORMS
Printed on: Fri May 14 2021, 10:26:22 AM Official Status: Currently Official on 14-May-2021 DocId: 1_GUID-431F93A9-1 FEC-42AE-8556-AA5B604B2E36_8_en-US. (EST). Printed by: Deborah Nishikawa Official Date: Official as of 01-May-2021 Document Type: GENERAL CHAPTER @2021 USPC. 1. 1151 PHARMACEUTICAL DOSAGE FORMS . Change to read: GENERAL CONSIDERATIONS. This chapter provides general descriptions of and definitions for drug products, or DOSAGE FORMS , commonly used to administer the drug substance (active PHARMACEUTICAL ingredient; API). It discusses general principles involved in the manufacture or compounding of these DOSAGE FORMS . A glossary is provided as a nomenclature resource and should be used in conjunction with the Nomenclature A DOSAGE form is a PHARMACEUTICAL preparation consisting of drug substance(s) and/or excipient(s) to facilitate dosing, administration, and delivery of the content of the drug product or placebo to the patient. The design, materials, manufacturing, and testing of all DOSAGE FORMS target drug product quality.
dosing regimen. These considerations, organized by route of administration, are detailed in Injections and Implanted Drug Products (Parenterals)—Product Quality Tests á1ñ, Oral Drug Products—Product Quality Tests á2ñ, Topical and Transdermal Drug
Loading..
Tags:
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document: